Drug Epidemiology and Post-Marketing Surveillance

Spontaneous Reporting: The Analysis of Postmarketing Drug Surveillance Data at the U.S. Food and Drug Administration; T.P. Gross. Pharmacovigilance in France; B. Begaud. Traditional Clinical Epidemiology Methods as Applied to Pharmacoepidemiology: The Use of Cohort Studies in Pharmacoepidemiology; T. Creagh-Kirk. Use of Automated Databases for Pharmacoepidemiology: Screening for Unknown Effects of Newly Marketed Drugs; J.L. Carson, B.L. Strom. Hospital Pharmacoepidemiology: Hospital Data Sources; J.K. Jones. New Methodologic Developments: Approaches to Evaluating Causation of Suspected Drug Reactions; J.K. Jones. Pharmacoeconomics; H. Glick, R. Kington. Selected Examples of Regulatory and Commercial Importance: The Triazolam Experience in 1979 in the Netherlands; R.H.B. Meyboom. Eleven additional articles. Index.Strom, B. L. is the author of 'Drug Epidemiology and Post-Marketing Surveillance' with ISBN 9780306440991 and ISBN 0306440997.